MD Anderson Cancer Center
Houston, Texas, 77030, United States
Location status: Recruiting
NCT Number: NCT06545604
To provide a comprehensive yoga therapy (CYT) program to patients with ovarian, fallopian tube, or primary peritoneal cancer who are scheduled to receive chemotherapy and then undergo surgery. Researchers want to learn about the effects of the program on patients' quality of life and other outcomes described below.
Interested in participating?
Request Info18 year and older
Female
Interventional
Not applicable
Houston, Texas, 77030, United States
Location status: Recruiting
Primary Objectives:
Primary Objective: to assess the feasibility of a CYT prehabilitation program in women with ovarian cancer scheduled to receive NACT and IDS. Feasibility criteria will include the percent of eligible patients who consent to participate (feasibility is defined as 30% of those approached and are eligible end up consenting) and study retention by the last follow-up (feasibility is defined as 60% of those undergoing surgery remaining in the study and providing some data at baseline and at last follow-up timepoint).
Secondary Objectives:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Two visits per week with a yoga therapist while receiving neoadjuvant chemotherapy to cover dietary counseling, yoga-based movement practices, breathwork practices, mind practices, and behavioral support for the purpose of preparing patients' mind and body for a planned surgery.
Usual care supportive services while receiving neoadjuvant chemotherapy.
Time frame: Through study completion; an average of 1 year
Contact information is provided by the study sponsor or research team.
M.D. Anderson Cancer Center
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06040970
Adnexal Diseases, Endocrine Gland Neoplasms
New York, United States
View Trial DetailsNCT07042802
Adnexal Diseases, Endocrine Gland Neoplasms
Beijing, Beijing Municipality, China
View Trial DetailsNCT03412877
Adnexal Diseases, Blood Protein Disorders
Bethesda, Maryland, United States
View Trial DetailsNCT02830724
Adenocarcinoma, Adnexal Diseases
Bethesda, Maryland, United States
View Trial Details